China’s biotechnology sector is experiencing a transformative surge, marked by billion-dollar deals and a 60% stock rally in 2025, outpacing even AI-driven markets China’s biotechnology sector has emerged as a formidable force, shaking off a four-year slump to become one of Asia’s hottest markets. The Hang Seng Biotech Index has surged by approximately 60% in 2025, a rally that has outstripped the 17% gain in China’s tech stocks, driven by …
stock market
Chinese stocks experienced their biggest single-day gains since 2008 on Monday, 30 September, with investor sentiment buoyed by a week of government stimulus aimed at revitalising the economy. Indexes, including the benchmark CSI-300 blue-chip index, the Shanghai Composite Index, the Shenzhen Composite Index, and Hong Kong’s Hang Seng Index, rose between 3.3% and 11%, restoring US$1.8 trillion in value across the three cities’ exchanges during the rally. China’s Tech Index, …
China’s markets have continued a multi-year slide in recent days, prompting China’s securities regulator to introduce new measures and even change its senior leadership. On Monday, 5 February, China’s blue-chip CSI 300 Index fell by close to 5%, hitting its lowest level since 2019. Confidence in the market has waned amid an economic turndown, driven by issues such as a debt-ridden property industry. The latest fall came on a day …

